2008 was another stellar year for the world vaccine market. Sales grew 21.5% since 2007 to reach $19.2 billion. Few areas of pharmaceuticals have seen the fast-moving developments in the marketplace that the vaccine market has...
"New products and better-than-expected profits, as well as merger activity, have transformed the vaccine marketplace," says Bruce Carlson, publisher of Kalorama Information. "Continued sales of influenza and cervical cancer vaccines have provided a foundation for growth in the adult market. Meanwhile, the pediatric market was fueled by several major products including Wyeth's pneumococcal vaccines Prevnar and Merck's new rotavirus vaccine TotaTeq."
Take a minute to read the report to get a sense of how important your
Vaccines are a 19.2 Billion dollar a year business. I am sure that with that kind of cash at play that the medical establishment is not at all biased as to vaccine safety.
I don't wanna hear that vaccines are not a money making venture any more.
Gotta run now and go get me some "Tota Teq".
As always, your posts cut right to the heart of the problem. Thanks for all that you do to present the facts in such a clear manner.
I couldn't say it better than Chrissy
Post a Comment